Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Endometrial Cancer|Cervical Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: PTK787
Sponsor: Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital|Massachusetts General Hospital